mifepristone has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosland, MC; Clare, SE; Helenowski, I; Hosseini, O; Khan, SA; Kim, JJ; Lee, O; Patel, P; Schipma, MJ; Shidfar, A; Wang, M; Xuei, X | 1 |
| Ray, DW; Singh, N; Sommer, P; Taylor, KM; Vosloo, D; Wheeler, R | 1 |
2 other study(ies) available for mifepristone and Carcinogenesis
| Article | Year |
|---|---|
Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes.
Topics: Animals; BRCA1 Protein; Breast Neoplasms; Carcinogenesis; Disease Models, Animal; Epithelial Cells; Female; Humans; Mammary Glands, Animal; Mastectomy; Mice; Mifepristone; Norpregnadienes; Receptors, Progesterone; Stromal Cells; Tumor Microenvironment | 2021 |
The tobacco carcinogen NNK drives accumulation of DNMT1 at the GR promoter thereby reducing GR expression in untransformed lung fibroblasts.
Topics: Carcinogenesis; Carcinogens; Cell Line; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Mifepristone; Nitrosamines; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Tobacco Smoking | 2018 |